Rising rates of colorectal cancer, especially among young people, have researchers seeking to identify ways to increase cancer screening. Three new studies published in JAMA Network and JAMA Oncology ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma (PPARG), showed early signs of clinical benefit in patie ...

Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral lesions significantly reduced lesion size and risk of cancer progression, sparing most patients from ...

Researchers previously established that exercise may reverse some of the cognitive symptoms associated with “ chemo brain,” which may arise from cancer and treatment and include deficits in memory, ...

Carranza, a child development professional who grew up swinging through trees and swimming in rivers in El Salvador, said she feels at home in the forest at the outdoor preschool she co-founded. She ...

The researchers found that for men with low PSA levels prior to radiotherapy, adding hormone therapy, whether short-term or long-term, did not improve overall survival. Men with higher PSA levels ...

When we set about to enhance SEER, we worked with and sought feedback from many groups and experts. This outreach allowed us to better understand the cancer research community’s needs and the ...

“The latest data from the Phase I trial are encouraging,” lead investigator Vinod Balachandran, MD, of Memorial Sloan Kettering Cancer Center, said in a news release. “They suggest this ...

People who received high-dose vitamin D3 did not experience additional concerning side-effects or toxicities compared with those who got the standard dose, Ng reported. But over a median 20 months of ...

Social media was abuzz this week over an article in The Australian about a tech entrepreneur who used artificial intelligence to create a customized vaccine to cure his dog’s cancer. Many commenters ...

A new study highlights the scale and scope of the Trump administration’s termination of National Cancer Institute (NCI) research grants since it slashed cancer research funding in early 2025 and cut ...

A next-generation armored CAR-T therapy called C-CAR031 led to regression of liver tumors in more than half of patients with advanced hepatocellular carcinoma, rising to 75% for those who received the ...